2. 您的位置
3. 首页
4. 会议论文
5. A novel mutation in Wiskott-Aldrich syndrome and successfully treated with umbilical cord blood tran

A novel mutation in Wiskott-Aldrich syndrome and successfully treated with umbilical cord blood tran

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户：daluo13613152523

【摘 要】

：

Objective Wiskott-Aldrich syndrome (WAS) is a rare X-linked primary immune deficiency (PID) characterized by micro-thrombocytopenia,eczema,and impaired cellular and humoral immunity.WAS is associated

【作 者】

：

Xiaoyu Zhu Baolin Tang Changcheng Zheng Huilan Liu Kaidi Song Zimin Sun 

【机 构】

：

Department of Hematology,Anhui Provincial Hospital Affiliated with Anhui Medical University

【出 处】

：

The 35th World Congress of the International Society of Hema

【发表日期】

：

2014年5期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

Objective Wiskott-Aldrich syndrome (WAS) is a rare X-linked primary immune deficiency (PID) characterized by micro-thrombocytopenia,eczema,and impaired cellular and humoral immunity.WAS is associated with a high incidence of auto-immunity and lymphoreticular malignancies.

其他文献

Comparative Analysis of Single-Institute Transplantation From Unrelated Cord Blood and Related Donor

Objective Unrelated donor cord blood transplantation (CBT),as an alternative matched-unrelated or mismatched-related peripheral blood or bone marrow transplantation,has become a widely accepted treatm

会议

Absolute lymphocyte count on day 30 and acute graft-versus-host disease associated with outcomes of

Umbilical cord blood transplantation (UCBT) is increasingly used as an alternative treatment for hematologic malignancies.However,the simple parameters for predicting the outcomes of patients after UC

会议

Similar survival, but better quality of life after myeloablative transplantation using unrelated cor

This study included data from 185 consecutively treated patients,16 years of age or older,who underwent myeloablative transplantation using unrelated UCB (UCBT,n=70) or HLA-identical sibling donor per

会议

Decitabine as a conditioning regimen in haploidentical stem cell transplantation for refractory acut

Chemotherapy can increase treatment-related mortality associated with future hematopoietic stem cell transplantation (HSCT) for patients with relapsed/refractory acute myeloid leukemia (AML).There is

会议

Single center research on haploidentical hematopoietic stem cell transplantation to perdiatic leukem

Objective Observe the clinical effect of haploidentical HSCT (haplo-HSCT) to treat pediatric leukemia.Method During July 2007 to September 2011,24 children were subjected in haploidentical HSCT.Then,t

会议

Outcome of sequential autologous stem cell transplantation on aggressive non-Hodgkin lymphoma-a sing

Aim Retrospectively analyzethe role of sequential autologous stem cell transplantation (ASCT) in aggressive NHL.Method 121 newly diagnosed patients with aggressive NHL,including 68 males and 53 female

会议

Anti-thymocyte Globulin Could Improve the Outcome Of Allogeneic Hematopoietic Stem Cell Transplantat

Background Aggressive T-cell lymphomas represent 10 ％to 15 ％of non-Hodgkins lymphomas in adults.Patients withrelapsed or refractory disease are generally considered incurable with conventional therapi

会议

Negative association of donor age with CD34+ cell dose in mixture allografts of G-CSF-primed bone ma

Background The effects of donor characteristics on CD34+ cell dose remains controversial.Recently,we developed a novel haploidentical transplant protocol,in which mixture allografts of granulocyte col

会议

Outcome of patients with acute myeloid leukemia who underwent autologous and allogeneic hematopoieti

Objective To investigate the outcome of autologous hematopoietic stem cell transplantation(auto-HSCT) for patients with acute myeloid leukemia(AML),we retrospectively compared the outcomes of auto-HSC

会议

Salvaged single-unit cord blood transplantation for 19 patients with progressive hematologic maligna

Object The treatment for progressive hematologic malignancies is dismal,but few clinical studies have investigated the role of salvaged unrelated cord blood transplantation (CBT) for these patients.

会议